One of the nice things about shorts is that you can always count on them to bring up every possible negative about a stock. However, the only problem is that there is a research report dated May 2 from a short-seller firm, Culper Research. After they cash in on the Short, they then turn around and ride the wave back up, which happens to most companies they've done this to. The problem is this is a highly speculative play for most investors. In no event should Culper or any affiliated party be liable for any direct or indirect trading losses caused by any . CleanSpark, Inc., a Nevada corporation, is in the business of providing advanced software and controls technology solutions to solve modern energy challenges. Some research into Culper Research. ET after the short-selling group Culper Research published a new report criticizing the company's latest clinical trial . Following publication of any research, we intend to continue transacting in the securities covered herein, and we may be long, short, or neutral at any time hereafter regardless of our initial recommendation, conclusions, or opinions. Please declare your traffic by updating your user agent to include company specific information. You further agree to do your own research and due diligence, consult your own financial, legal, and tax advisors before making any investment decision with respect to transacting in any securities covered herein. Your request has been identified as part of a network of automated tools outside of the acceptable policy and will be managed until action is taken to declare your traffic. 10 czerwca 2022 I'd love to hear your thoughts on what I've found below and hopefully help connect some of these dots. from 8 AM - 9 PM ET. And 9380 has actually been buying more stock in Aterian since it was acquired by the company. Site Map, Advertise| Is This Warren Buffett Stock a Buy After Its Dividend Boost? Town square for LifeMD ($LFMD) stakeholders, Press J to jump to the feed. If you can't trust management, or its numbers, you really shouldn't be in a stock. In no event should Culper or any affiliated party be liable for any direct or indirect trading losses caused by any . Reddit and its partners use cookies and similar technologies to provide you with a better experience. Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. That request was submitted in December 2020 and according to the SEC FOIA request logs, was done so by a Jeff Bourland linkedin on behalf of an unknown entity, perhaps the "Family Office" listed on his Linkedin. Not a Bloomberg Law Subscriber?Subscribe Now. Invest better with The Motley Fool. With Such Low Win Rates, Should Law Firms Respond to So Many RFPs? Docent led tours every 30 minutes of the Spies! Verified account Protected Tweets @; Suggested users Among its raft of accusations, Culper wrote that the trial is significantly smaller than those conducted for other COVID drug candidates and demonstrated a worryingly high mortality rate. Accounting issues always cause stress for investors. SALT LAKE CITY, January 21, 2021 -- CleanSpark, Inc. (Nasdaq: CLSK), ("CleanSpark, or "the Company"), an advanced software and controls technology solutions company focused on solving modern energy challenges, has become aware of a report making false accusations against CleanSpark and its officers. The rather eclectic biotech -- it has a female contraceptive product, FC2, on the market, and is developing cancer drugs -- has attracted much interest because of the apparently promising sabizabulin. Join The Legal Intelligencer now! LexisNexis and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. Feel like going after another group of asshole short sellers trying to screw over us regular investors? Alpilean creator (Zach Miller) and medical research editor (Dr. Matthew Gibbs) medically concluded that the longest-lived people on the planet use a "secret trick" on the Alpine ice every night. Investors should probably take this allegation with a grain of salt, as Culper Research is an anonymous outfit and the author of the report is a mystery. Women, Influence & Power in Law UK Awards 2023, Legalweek Leaders in Tech Law Awards 2023, WORKERS COMPENSATION ATTORNEY - Hartford, CT, Offering an Opportunity of a Lifetime for Personal Injury Lawyers, What Does Your Business Agreement Really Mean? A recent report by Culper Research contains numerous false and misleading statements about our company. The industry-leading media platform offering competitive intelligence to prepare for today and anticipate opportunities for future success. culper research legitmichelle fleury ancestry. $10/person - click to reserve your spot! Our focus was and continues to be on acquiring high performing businesses that offer opportunities for growth. In a 10-tweet thread digesting the report and posted on Monday, Culper accused Veru of "glaring anomalies" in its phase 3 clinical trial of coronavirus drug sabizabulin. LFMD execs were not involved, and left the company. The Motley Fool has no position in any of the stocks mentioned. About Us. Federal Judge: Lancaster Investment Firm, Executives Must Pay $2M in Civil Penalties, Restitution, Special Master in MoneyGram Feud at SCOTUS Has Surprise Change of Mind, In Jackson's First Majority Opinion, SCOTUS Curbs Delaware's Collection of Unclaimed Property, Class Action Accusing BOA of Inadequate Notice Before Reposessions Hits Federal Court, Law.com Editors and Analysts Offer Top Trends to Watch for 2023. I do wish to raise two issues: Rivington and my background. In its report, Culper Research makes a series of claims concerning LifeMD, its executives, and its operations which, if true, could be devastating to the healthcare company and its shareholders. All expressions of opinion are subject to change without notice, and Culper does not undertake to update or supplement this report or any of the information contained herein. According to documents Aterian filed with the SEC on April 29, 9380 Macarthur does indeed own almost 5 million shares, or 16.2% of the company. WOW Very BOLD and INTENSE claims made by Culper Research about Blink Charging Fraud!! You agree that the information on this website is copyrighted, and you therefore agree not to distribute this information (whether the downloaded file, copies / images / reproductions, or the link to these files) in any manner other than by providing the following link http://www.culperresearch.com The failure of Culper to exercise or enforce any right or provision of these Terms of Service shall not constitute a waiver of this right or provision. Each attorney is granted unlimited access to high quality, on-demand premium content from well-respected faculty in the legal industry along with administrative access to easily manage CLE for the entire team. I took a deep look into the Culper Research short report and this is what I found.Culper Research short report on Core Scientifichttps://img1.wsimg.com/blobb. CleanSpark plans to apply its technologies with a goal of mining bitcoins at the lowest energy prices in the United States. The Cable Car website is down right now, but does indicate a connection to an investment partnership with the Funicular Fund. The complaint, over an alleged short-and-distort stock scheme, was filed by Gordon Rees Scully Mansukhani on behalf of LifeMD Inc., CEO Justin Schreiber and CTO Stefan Galluppi. Copyright 2023 ALM Global, LLC. More recently, Culper tweeted the response from SEC on a FOIA request for records pertaining to any investigations into OrthoPediatrics Corp., $KIDS. This makes them biased, of course, but no more biased than the shareholders who want the stock to go up. With this subscription you will receive unlimited access to high quality, online, on-demand premium content from well-respected faculty in the legal industry. If you're a natural optimist, shorts are handy as a devil's advocate, reminding you of all the bad things that can happen to your stock. We reserve the right to block IP addresses that submit excessive requests. For example, if it has to redesign the study and start from scratch the costs could go up. Theyre calculating that LFMD spends an average of $36 in marketing costs per webpage visitor for REXMD while HIMS spends an average of $2.14 per website visitor for its products . Aterian (f.k.a. REKR reported $245,000 in Oklahoma revenue for itself, and $1,000,000 in revenue for the state of Oklahoma - "over 25,000" notices of non-compliance were issued, but REKR . An immediate avalanche of selling started at the open of the 6th, suggesting that news of the basket trial was a bad thing. You further agree to do your own research and due diligence, consult your own financial, legal, and tax advisors before making any investment decision with respect to transacting in any securities covered herein. Invest better with The Motley Fool. Published on June 1, 2022 June 3, 2022. We are aware that litigation premised on the so-called "Culper Report" has been filed and that plaintiff's firms are trolling for additional shareholders. 1125 N. Charles St, Baltimore, MD 21201. Veru Inc. (VERU) fell 6.7% after Culper Research released another short report on the oncology-focused biopharmaceutical company.Culper alleged in the report that at baseline, the. Where This Leaves Investors in Veru Stock. The allegations the firm makes are of a nature that most potential investors in Veru stock are likely to read. We think that if BCII was a fully-legitimate operation, then at the least, it would be able to recruit a legitimate lawyer. Down 94%, Is Carvana Stock a Buy-the-Dip Opportunity? To the best of our ability and belief, all information contained herein is accurate and reliable, and has been obtained from public sources we believe to be accurate and reliable, and who are not insiders or connected persons of the securities covered herein or who may otherwise owe any fiduciary duty or duty of confidentiality to the issuer. On the other hand, shorts are always future buyers of your stock. This implies that it could end up wasting a lot of its cash if the Phase 3 clinical study is not successful in obtaining FDA EUA approval. So the names of the defendants in the lawsuit against Redwood were as follows. Prior to co-founding Culper Capital Partners, he served as Majority Shareholder, Chairman & CEO of Glebar Company ("Glebar"), a role which he held from April 2013 to March 2020. Culper Research, an activist short-seller that in its words "seek[s] to expose companies which have misrepresented their operations, failed to disclose significant risks, misappropriated capital . They short the company, post these reports, and reap the benefits of people over reacting. Use of Culper Research's ("Culper") research is at your own risk. The Motley Fool has a disclosure policy. By downloading from or viewing material on this website you agree to the following Terms of Service. *Average returns of all recommendations since inception. Capacity is expected to increase to over 300 PH/s in mining capacity by early 2021. The publisher of this false report is an unknown entity or group hidden behind the facade of "Culper Research," which disguises the identity of the actual author(s). Managing Partner, Chief Investment Officer. Please. Home; About us; Contact us; Twitter Seeking Alpha Stocktwits; . The second major issue the Culper report has with Veru is the quality of management. Although we identified the historical legal concerns raised in the report, they were unrelated to the acquired businesses. What kind of manipulation and block trades? Did anyone read this? "LifeMD uses technology to make health care more accessible to people from all walks of life. Not only has Aterian has not disclosed that its largest acquisition was from a felon who served prison time, but despite 5 elapsed months, the Company has failed to provide audited financials for the Smash Assets, leaving its S-3 shelf filing ineligible. CleanSpark cautions you that statements in this press release that are not a description of historical facts are forward-looking statements. It is very clear that one of their tactics is to submit FOIA requests for information regarding investigations into companies they are attacking, which if you know the Freedom of Information Act, is information that would never be released to the public. The Company also owns and operates a fleet of over 3,400 ASIC (application-specific integrated circuit) Bitcoin miners producing over 200 PH/s in mining capacity. While the short report is lengthy, here is part of what Culper said. On November 15, 2022, Culper Research published a short report on Treace (the "Culper Report"). Spying is a secret business and thus research into it is most difficult. Getting The Talent Balance Right: From Layoffs to Laterals to Mergers, How Can Firms Staff for Success? Financial Market Data powered by FinancialContent Services, Inc. All rights reserved. Here's what the company said in part. If Justin and Stefan were involved in anyway they would have been on the list of named defendants. CleanSpark, Inc. Investor Relations(801) 244-4405[emailprotected], Cision Distribution 888-776-0942 When typing in this field, a list of search results will appear and be automatically updated as you type. The Austin-based company went public on the Nasdaq via a special purpose acquisition vehicle, or SPAC, in January 2022. At this point, the connection between all these entities and Culper is unclear, beyond the fact that Culper posted the response to Ma-Weaver/Cable Car Capital's SEC FOIA request back in December. Value oriented and event driven investor. The Motley Fool has a disclosure policy. LFMD responded to short report, denying the claims and will report something in detail soon. In no event should Culper or any affiliated party be liable for any direct or indirect trading losses caused by any information on this site. In reality, they are simply conspiring to drive down the prices of stocks they take short positions in. On July 21, 2022, shares of Energy Vault fell over 6% after Culper Research issued a report that calls into serious question the business and operations of the company. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. Cost basis and return based on previous market day close. The two short-sellers claimed that SOS stock was an . On Friday, Hindenburg Research and Culper Research released scathing reports on SOS Ltd (NYSE: SOS ), a Chinese cryptocurrency mining company. Law360 (September 20, 2021, 7:52 PM EDT) -- A negative report from stock research firm Culper Research about telehealth company LifeMD Inc. was part of a "short and distort" stock scheme to defame . Overall, it's been ~15 years since I've seen a decent group go after microtubules in cancer. Unlimited access to The Legal Intelligencer, Access to additional free ALM publications, 1 free article* across the ALM subscription network every 30 days, Exclusive discounts on ALM events and publications. (On March 8 the company appointed Arturo Rodriguez to succeed Fabrice Hamaide in the position.) Investors might want to watch out. If You Invested $1,000 in Veru in 2020, This Is How Much You Would Have Today, 2 Reasons to Avoid a Roth 401(k) for Your Retirement Savings, Want $1 Million in Retirement? The publisher of this false . Special Collections, a division of Stony Brook University Libraries (SBU Libraries) is the owner and steward of two American Revolutionary War-era, Culper Spy Ring letters authored by George Washington. By accepting all cookies, you agree to our use of cookies to deliver and maintain our services and site, improve the quality of Reddit, personalize Reddit content and advertising, and measure the effectiveness of advertising. Investors should probably take this allegation with a grain of salt, as Culper Research is an anonymous outfit and the author of the report is a mystery. For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. Also, apparently, most of the patients in the study were outside of the U.S. So let's take a look at what Culper is saying about Aterian. Did these scumbags have any insider information? For that matter, changing the name of your company a week before a short attack might make people nervous, too. Guys, this is a classic short attack. Yes, it works for cancers, but it does the same to all normal tissue.